-

01:37:51 PM

LIVE Real Time ANIX Stock Market News

ANIX - Anixa Biosciences Inc

04/19/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Food and Drug Administration (US FDA) has requested additional information

RHEA-AI

neutral

04/05/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that based on Proof of Concept (POC) animal study results, it will progress to the next stage of

RHEA-AI

neutral

03/22/21 10:00 PM

Nasdaq : ANIX

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that, due to demand, the underwriter has agreed to increase the

RHEA-AI

neutral

03/22/21 5:18 PM

Nasdaq : ANIX

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it has entered into an underwriting agreement with H.C.

RHEA-AI

neutral

03/22/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that an IND (Investigational New Drug) application for its ovarian cancer CAR-T (Chimeric

RHEA-AI

neutral

03/12/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the European Patent Office has issued and published the first European patent for its

RHEA-AI

neutral

03/08/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Anixa's Chief Executive Officer, Dr. Amit Kumar, has been invited to present at the

RHEA-AI

neutral

03/04/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the European Patent Office has issued the first European patent for Anixa's novel CAR-T

RHEA-AI

positive

02/25/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that Dr. Amit Kumar, Anixa's Chief Executive Officer, will present at the virtual H.C.

RHEA-AI

neutral

02/16/21 8:30 AM

Nasdaq : ANIX

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that animal testing has commenced with two proprietary compounds that have shown potency in in

RHEA-AI

neutral